Growing pains for biopharmaceuticals.
Centre for Medicines Research International, Surrey, UK. gashton@cmr.org
G
G
Ashton
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001709:Biotechnology / Q000191:economics* / Q000331:legislation & jurisprudence / Q000639:trends*; D004345:Drug Industry / Q000191:economics* / Q000331:legislation & jurisprudence / Q000639:trends*; D006801:Humans; D011994:Recombinant Proteins / Q000627:therapeutic use*; D012106:Research / Q000191:economics / Q000639:trends; D013997:Time Factors; D014481:United States; D014486:United States Food and Drug Administration
D000911:Antibodies, Monoclonal; D011994:Recombinant Proteins